Impact of serum-derived bovine immunoglobulin/protein isolate therapy on irritable bowel syndrome and inflammatory bowel disease: a survey of patient perspective.

When comparing male and female patients in the combined IBS and IBD group, a higher percentage of female patients reported a 25%–50% decrease in stool frequency and a lower percentage reported a >75% decrease, although these differences did not reach statistical significance (data not shown).

also in 111,027 other papers